Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation)
Atlas Antibodies
- Catalog No.:
- ATL-HPA014963-25
- Shipping:
- Calculated at Checkout
$478.00
Gene Name: SLC13A2
Alternative Gene Name: NaDC-1
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000001095: 67%, ENSRNOG00000010337: 71%
Entrez Gene ID: 9058
Uniprot ID: Q13183
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
| Product Specifications | |
| Application | IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | ATSAMMVPIAHAVLDQLHSSQASSNVEEGSNNPTFELQEPSPQKEVTKLDNGQALPVTSASSEGRAHLSQKHLHLTQCMSLCVCYSASIGGIATLTGTAPNLVLQGQINSLFPQNGNVV |
| Gene Sequence | ATSAMMVPIAHAVLDQLHSSQASSNVEEGSNNPTFELQEPSPQKEVTKLDNGQALPVTSASSEGRAHLSQKHLHLTQCMSLCVCYSASIGGIATLTGTAPNLVLQGQINSLFPQNGNVV |
| Gene ID - Mouse | ENSMUSG00000001095 |
| Gene ID - Rat | ENSRNOG00000010337 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) | |
| Datasheet | Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) at Atlas Antibodies |
| Documents & Links for Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) | |
| Datasheet | Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) Datasheet (External Link) |
| Vendor Page | Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) |
| Citations for Anti SLC13A2 pAb (ATL-HPA014963 w/enhanced validation) – 1 Found |
| Hall, Adam E; Pohl, Sebastian Öther-Gee; Cammareri, Patrizia; Aitken, Stuart; Younger, Nicholas T; Raponi, Michela; Billard, Caroline V; Carrancio, Alfonso Bolado; Bastem, Aslihan; Freile, Paz; Haward, Fiona; Adams, Ian R; Caceres, Javier F; Preyzner, Paula; von Kriegsheim, Alex; Dunlop, Malcolm G; Din, Farhat V; Myant, Kevin B. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer. Nature Communications. 2022;13(1):2791. PubMed |